SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!
缘起缘灭
Lv5
1420 积分
2021-06-21 加入
最近求助
最近应助
互助留言
Discovery of 3-(3-(4-(1-Aminocyclobutyl)phenyl)-5-phenyl-3H-imidazo[4,5-b]pyridin-2-yl)pyridin-2-amine (ARQ 092): An Orally Bioavailable, Selective, and Potent Allosteric AKT Inhibitor
1天前
已完结
Design, synthesis, and biological evaluation of diphenyl ether substituted quinazolin-4-amine derivatives as potent EGFRL858R/T790M/C797S inhibitors
8天前
已完结
Discovery, synthesis and biological evaluation of novel isoquinoline derivatives as potent indoleamine 2, 3-dioxygenase 1 and tryptophan 2, 3-dioxygenase dual inhibitors
8天前
已完结
Discovery of Novel N2-indazole Derivatives as Phosphodiesterase 4 Inhibitors for the Treatment of Inflammatory Bowel Disease
1个月前
已完结
Discovery of Clinical Candidate NTQ1062 as a Potent and Bioavailable Akt Inhibitor for the Treatment of Human Tumors
1个月前
已完结
Design, synthesis and biological evaluation of a new series of imidazothiazole-hydrazone hybrids as dual EGFR and Akt inhibitors for NSCLC therapy
1个月前
已完结
Bridged Proteolysis Targeting Chimera (PROTAC) Enables Degradation of Undruggable Targets
1个月前
已完结
Development of PROTAC degrader probe of CDK4/6 based on DCAF16
1个月前
已完结
Development of PROTAC Degrader Probe of CDK46 Based on DCAF16
1个月前
已关闭
Targeted Degradation of CDK4/6: An Innovative Approach to Overcoming Cancer Drug Resistance
1个月前
已完结
没有进行任何应助
已获取【积分已退回】
1个月前
已获得【积分已退回】
9个月前
信息错误,重新提交信息【积分已退回】
1年前
点赞
3年前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论